Unparalleled Flexibility

in Panel Design!

Discover mFluor™ Violet

Conjugated Antibodies

Growing Selection of 14,000+ Targets!

Learn More
mFluor Violet Conjugated Antibodies

Novus Biologicals, a Bio-Techne brand,

Awarded Bioz Rapid Star Winner

For Fastest Growing Supplier of

Secondary Antibodies

Search Our Award-Winning Secondaries

Learn more about the award recognized by 16 million researchers worldwide at bioz.com

Novus Awarded Bioz Rapid Star

Explore Our New


IHC Guide

Optimize and troubleshoot your IHC assays

Get the Complete Guide
IHC Handbook Update

Flow Cytometry

Panel Builder

Streamline the Panel Design Process

Build Your Panel
Flow Cytometry Panel Builder

Novus Biologicals is a trusted leader in quality life science reagents. Backed by our 100% Guarantee.

On-Demand Webinar:

Exploiting Tumor Hypoxia for Targeted Immunotherapy

New for You at Novus

Our Catalog Keeps Growing!

Check out innovative products including new mFluor™
Violet Conjugated Antibodies to expand your flow panel
and antibody sampler packs to expedite your research.

Scientific Resources

Flow Cytometry Handbook

Learn about flow cytometry workflow, protocols and troubleshooting tips.

Western Blot Handbook

Learn about Western Blot systems, protocols, troubleshooting, and more!

IHC Handbook

Learn the basics of IHC, standard protocols, plus troubleshoot technical issues.

Dr. Sampson’s research focuses on host-microbe interactions at the interface of Parkinson’s disease, Alzheimer’s disease, and other neurological illnesses. His work aims to reveal new pathways at the microbiota-brain axis.

Jagannath’s research focuses on the cellular mechanisms in fibrosis and foreign body rejection triggered by implantable biomaterials. Learn about his passion for biomaterials’ research, science communication and teaching.

Novus Biologicals Blogs

By Jennifer Jones, M.S.

Biosimilar Antibodies: Imitation Meets Innovation

In the ever-evolving medical landscape, a new class of pharmaceuticals is emerging as a game-changer, poised to transform the way we approach treatment options: ...

Read More